During the November hearing on the Clio case, Whitestrips was called as the largest product introduction in P&G‘s history by the lead inventor, Paul Sagel. Whitestrips was considered as the best products of the decade by Advertising Age. Whitestrips occupy 67% of the $386.6 million of market of teeth whitening in North America. That’s in part due to aggressive enforcement of the patents on the product by P&G. Johnson & Johnson (NYSE:JNJ) had stopped its Listerine based strips in 2008 as part of its settlement with P&G. Johnson & Johnson (NYSE:JNJ) net profit margin is 20.90% and weekly performance is 1.10%. On last trading day company shares ended up $100.98. Analysts mean target price for the company is $104.84. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 3.17%.
Top American companies including pharmaceutical giant Pfizer Inc. (NYSE:PFE) are saving at least $550 billion in taxes by holding profits in overseas tax havens, according to a report Monday by the advocacy group Citizens for Tax Justice. Pfizer Inc. (NYSE:PFE) shares fell -0.57% in last trading session and ended the day on $29.49. PFE Gross Margin is 81.90% and its return on assets is 23.00%. Pfizer Inc. (NYSE:PFE) quarterly performance is -7.00%.
Stryker Corporation (NYSE:SYK) Director William Parfet sold 2,062 shares of Stryker stock in a transaction that occurred on Wednesday, May 14th. The shares were sold at an average price of $80.10, for a total transaction of $165,166.20. Following the completion of the sale, the director now directly owns 272,119 shares of the company’s stock, valued at approximately $21,796,732. Stryker Corporation (NYSE:SYK) shares moved down -0.40% in last trading session and was closed at $80.27, while trading in range of $80.12 – $80.58. Stryker Corporation (NYSE:SYK) year to date (YTD) performance is 7.24%.
Stock analysts at Oppenheimer reduced their target price on shares of Integra LifeSciences Holdings Corp. (NASDAQ:IART) from $57.00 to $55.00 in a report issued on Friday, American Banking News reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price objective points to a potential upside of 24.27% from the company’s current price. Integra Lifesciences Holdings Corp (NASDAQ:IART) ended the last trading day at $44.82. Company weekly volatility is calculated as 1.62% and price to cash ratio as 11.32. Integra Lifesciences Holdings Corp (NASDAQ:IART) showed a positive weekly performance of 0.79%.
CONMED Corporation (NASDAQ:CNMD) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 7, 2014 to all shareholders of record as of June 16, 2014. The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.80 per share, which is equivalent to a dividend yield of approximately 1.7% at current share prices. CONMED Corporation (NASDAQ:CNMD) net profit margin is 4.50% and weekly performance is -10.60%. On last trading day company shares ended up $44.35. Analysts mean target price for the company is $50.35. CONMED Corporation (NASDAQ:CNMD) distance from 50-day simple moving average (SMA50) is -2.77%.
Leave a Reply